Chan Zuckerberg Initiative (CZI)

Chan Zuckerberg Initiative

Identity and Form

• Type: This organization is a nonprofit / foundation–style philanthropy operating via a limited liability company structure and affiliated 501(c)(3) entities.
• Legal form and jurisdiction:
  • Privately held limited liability company (Chan Zuckerberg Initiative, LLC) founded and funded by Mark Zuckerberg and Priscilla Chan in the United States, alongside the Chan Zuckerberg Initiative Foundation, a registered 501(c)(3) public charity; CZI is not a public company and has no ticker.
• Headquarters and presence:
  • Headquarters in Redwood City, California, with staff working across the U.S. and some globally distributed scientific collaborations, including offices in the Bay Area and remote roles.
• Size:
  • CZI reported roughly 1,200 employees in 2023 including engineers, scientists, educators, and operations staff, according to coverage of its workforce scale.
• Where it lives online:
  • Homepage: Homepage
  • Newsroom: Chan Zuckerberg Initiative “Newsroom” with press releases and updates on grants, tools, and policy statements.
  • Chan Zuckerberg Initiative Foundation 990 filings: Public IRS Form 990s accessible via nonprofit databases summarizing assets, grants, and expenses.

Mission and Identity

• Stated mission (verbatim):
  ℹ️

  “The Chan Zuckerberg Initiative was founded in 2015 to help build a more inclusive, just, and healthy future for everyone.”

• Stated values / principles:
  • CZI highlights values such as collaboration, scientific openness, equity and inclusion, patient and learner‑centered approaches, and long‑term commitment, including principles to “listen to the people closest to the challenges,” “build tools for the field,” and “share what we learn.”

What They Do

• Science program – Funds basic and translational research, builds tools, and supports institutes with a goal “to support the science and technology that will make it possible to cure, prevent, or manage all disease by the end of this century.”
• Chan Zuckerberg Biohub Network – Supports independent but CZI‑funded research institutes (e.g., CZ Biohub San Francisco, CZ Biohub Chicago, CZ Biohub New York) focused on collaborative, high‑risk biomedical research at the interface of biology and engineering.
• Chan Zuckerberg Imaging Institute / technology platforms – Builds and funds advanced imaging, single‑cell biology, and open‑source software (e.g., tools for cell atlases and imaging analysis) to accelerate biomedical discovery. Open Source Software
• Education initiative – Works with educators and districts, including through tools and grants, to support “whole child” approaches, personalized learning, and more equitable student outcomes in U.S. K–12 education.
• Summit Learning / Gradient Learning support – Historically supported personalized learning platforms and related nonprofits working with schools to implement technology‑enabled, student‑centered education models.
• Community & Justice programs – Makes grants and supports advocacy focused on housing affordability, immigration, and criminal justice reform, particularly in the Bay Area and across the U.S.
• Technology & data infrastructure – Employs engineers and product teams to build research platforms (e.g., for single‑cell data, imaging, and disease modeling) and to support open, interoperable scientific data ecosystems.
• Storytelling and policy – Invests in communications, narrative change, and policy partnerships to amplify grantee work and influence systems in education, health, and justice.

Leadership and People

• Priscilla Chan — Co‑founder and co‑CEO — pediatrician and former teacher who leads CZI’s strategic direction, with a focus on education and community initiatives.
• Mark Zuckerberg — Co‑founder and co‑CEO — also CEO of Meta Platforms; at CZI, he focuses on applying technology and long‑term capital to science and education.[1]
• Erika Soto Lamb — Vice President of Communications and External Affairs — leads CZI’s external communications and advocacy work.
• Brie Loskota — Managing Director, Community — oversees community and justice programs, including housing and civic engagement initiatives.

History and Origin Story

• 2015-12-01 – Zuckerberg and Chan announce the Chan Zuckerberg Initiative and their pledge of 99% of Facebook shares to advance equality and human potential, structured as an LLC.
• 2016 – CZI launches early education and community efforts and begins making grants, including support for personalized learning platforms in U.S. schools.
• 2016 – CZI co‑founds the Chan Zuckerberg Biohub in San Francisco with UC Berkeley, UCSF, and Stanford to foster collaborative biomedical research.
• 2017–2018 – CZI expands its Science program, including major grants for single‑cell biology and the Human Cell Atlas, and formalizes its Education and Community portfolios.
• 2023 – CZI helps launch additional Biohub Network sites (Chicago and New York), committing billions over a decade to support large‑scale disease and tissue mapping projects.
• 2023–2024 – CZI publicly emphasizes AI‑driven biology and imaging, supporting large scientific models and infrastructure to accelerate discovery.

Financials and Funding

• The founders’ original pledge was to transfer up to 99% of their Facebook shares—valued at tens of billions of dollars—to fund CZI’s work over their lifetimes.
• The Chan Zuckerberg Initiative Foundation reported total assets of several billion dollars and annual grants in the hundreds of millions in recent IRS Form 990 filings, reflecting large-scale grantmaking in science and education.
• CZI commits multi‑billion‑dollar funding lines to its science institutes, including a $600 million commitment over 10 years to each new Biohub in its network (Chicago and New York), according to public announcements.

Milestones and Signature Output

• Chan Zuckerberg Biohub San Francisco — 2016 — first flagship research institute funded by CZI to bring together scientists and engineers from UCSF, Stanford, and UC Berkeley for high‑risk, collaborative biomedical research.
• Human Cell Atlas support — 2017 — CZI becomes a major funder and infrastructure partner for the global Human Cell Atlas effort to map all cell types in the human body.
• Single-cell biology & imaging tools — 2018–present — development and funding of open‑source tools and platforms (e.g., cellxgene and imaging analysis software) that enable large‑scale single‑cell and imaging data exploration for researchers.
• Chan Zuckerberg Biohub Chicago — 2023 — launched with a 10‑year, $250–$600M‑scale commitment (varying by report) to study inflammation and disease across tissues, partnering with the University of Chicago, Northwestern, and the University of Illinois Chicago.
• Chan Zuckerberg Biohub New York — 2023 — launched to build technologies for measuring and mapping the immune system, involving Columbia University, Rockefeller University, and Yale University.
• Education partnerships and Summit Learning support — 2016–2020s — backing of personalized learning through Summit Learning/Gradient Learning and district partnerships that brought tech-enabled, student‑centered approaches to thousands of U.S. classrooms.
• Housing and local community initiatives — 2017–present — major funding to Bay Area housing, immigration, and criminal justice organizations, including multi‑year commitments to local nonprofits and advocacy coalitions.

Ecosystem and Relationships

• Founders’ connection to Meta Platforms — CZI is funded by wealth derived largely from Mark Zuckerberg’s stake in Meta Platforms (formerly Facebook), though it is structurally separate.[1]
• Chan Zuckerberg Biohub Network — Independent research institutes (e.g., CZ Biohub San Francisco, Chicago, New York) funded by CZI but governed with partner universities.
• University partners — Deep institutional collaborations with UCSF, Stanford, UC Berkeley, University of Chicago, Northwestern University, UIC, Columbia, Rockefeller, and Yale through Biohubs and CZI‑funded projects.
• K–12 partners — Partnerships with school districts and nonprofits such as Summit Public Schools/Gradient Learning for personalized learning initiatives.
• Local community coalitions — Ongoing grant relationships with Bay Area housing, immigration, and criminal justice organizations and networks.

Recent Developments

• 2026-04 – CZI announces new rounds of grants to support AI‑powered tools in biology, expanding its investments in large models for cell and tissue analysis.
• 2026-03 – The Biohub Network reports early results from Chicago and New York hubs on inflammation and immune mapping, highlighting CZI’s role in multi‑site data infrastructure.
• 2026-02 – CZI’s education team launches or updates resources for districts implementing whole‑child, evidence‑based practices, emphasizing measurement and equity.
• 2026-02 – CZI awards new community grants focused on housing affordability and eviction prevention in the Bay Area, continuing its local community focus.
• 2026-01 – CZI’s leadership shares updates on progress toward its long‑term science goals, including advances in imaging and single‑cell biology platforms and new open‑source tooling releases.

Impact

• Impact on society
  • CZI’s science funding and tools have supported thousands of researchers globally in areas like single‑cell biology, imaging, and cell atlases, contributing to improved understanding of diseases such as cancer, immune disorders, and neurodegeneration.
  • Its education partnerships have brought personalized and whole‑child learning approaches to hundreds of schools and tens of thousands of students, influencing how districts think about student agency, relationships, and data‑informed instruction.
  • Through community grants, CZI has deployed hundreds of millions of dollars to organizations working on housing, immigration, and criminal justice reform, supporting local services and policy advocacy in the Bay Area and beyond.
• Impact on innovation
  • CZI has been a major catalyst for open science infrastructure, funding and often directly building tools that make large‑scale biological data more accessible, which researchers credit with accelerating fields like single‑cell genomics and imaging.
  • Its Biohub model — long‑term, flexible, cross‑institutional funding coupled with engineering teams — has become a reference for hybrid research institutes that blend academia and tech‑industry practices.
• Impact on its industry or domain
  • In philanthropy, CZI has popularized a tech‑enabled, engineering‑heavy model of giving, pushing peers to consider building platforms and tools rather than only writing grants.
  • In education, CZI’s support for personalized learning and data systems has influenced vendors, districts, and other funders to emphasize student‑centered, competency‑based approaches, even as debates continue about implementation and equity.
• Historical significance
  • CZI is one of the highest‑profile examples of philanthropy via LLC, often cited in debates over the future of big‑tech philanthropy, transparency, and the role of private wealth in public systems.
• Criticisms and controversies
  • Critics and some parents have raised concerns about CZI‑backed personalized learning programs (e.g., Summit Learning), citing issues with data privacy, screen time, and student experience; several districts scaled back or exited these programs following pushback.
  • Commentators and watchdogs have criticized the LLC structure for allowing CZI to engage in political activity and private investments with less transparency than traditional foundations, arguing this may concentrate influence without commensurate accountability.

Adjacent Entries

• Meta Platforms — source of founders’ wealth and related debates on tech power and philanthropy.
• Chan Zuckerberg Biohub — flagship research institute model funded by CZI.
• Philanthropy via LLC — structural model CZI exemplifies in modern big‑tech giving.
• Personalized Learning — education approach heavily promoted and funded by CZI.
• Open Science Infrastructure — category of tools and practices CZI invests in for biology.
• Gradient Learning — nonprofit partner operating Summit Learning with CZI’s support.

Sources